Fig. 1. iS-CellR pipeline overview

Slides:



Advertisements
Similar presentations
J Exp Bot. 2017;68(17): doi: /jxb/erx352
Advertisements

Figure 3: MetaLIMS sample input.
Fig. 1. RUbioSeq pipelines for exome variant detection and BS-Seq analyses. Dark gray boxes correspond to the main steps of the pipelines. Light gray boxes.
Figure 1: Necrobiosis lipoidica: Yellow-brown skin lesions with indurated borders located on both lower legs. Figure 1: Necrobiosis lipoidica: Yellow-brown.
Figure 1. Circular taxonomy tree based on the species that were sequenced in our study. Unless provided in the caption above, the following copyright applies.
Figure 1. Overview of the workflow of NetworkAnalyst 3.0.
Figure 1 The study area within Vienna Zoo is outlined in red
Figure 4. (A) Venn diagram showing the overlap of peaks differentially changed in DHT as compared to NT with peaks ... Figure 4. (A) Venn diagram showing.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1: Axial T2 W images of penis showed a well-defined septated area of 2 cm in the posterior aspect of ... Figure 1: Axial T2 W images.
FIGURE 1 Histological diagnoses divided into 8-year time frames (n = 1208). Unless provided in the caption above, the following copyright applies to the.
FIGURE 1 The effect of daprodustat on hemoglobin (Hgb) levels
Figure 1 The process of bone defect creation, implant insertion and ridge augmentation. (a) Creation of standardized ... Figure 1 The process of bone defect.
FIGURE 2 Responses to the question: regarding vasoactive drugs, does your centre use the following frequently, rarely ... FIGURE 2 Responses to the question:
FIGURE 1 Maternal (A) urinary aldosterone; (B) plasma active renin; (C) urinary AGT concentrations; and (D) plasma AGT ... FIGURE 1 Maternal (A) urinary.
Figure 1. Schematic illustration of CSN and NDM construction and our statistic model. (A) CSN and NDM construction. (i) ... Figure 1. Schematic illustration.
Figure 1. Ratios of observed to expected numbers of exon boundaries aligning to boundaries of domain and disorder ... Figure 1. Ratios of observed to expected.
Figure 1. autoMLST workflow depicting placement and de novo mode
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1. Comparison of weighted estimates of diarrhoea prevalence in children under five by country between PMA Figure 1. Comparison of weighted.
Fig. 1 Kaplan-Meier plot of cumulative incidence of cancer onset following dermatomyositis diagnosis stratified ... Anti-TIF1-Ab: anti-transcriptional.
Fig. 1 Mean change from baseline in ANC ± s. e
Point estimates with ... Point estimates with 95% CI. HR: hip replacement; KR: knee replacement. Unless provided in the caption above, the following copyright.
FIGURE 1 Participant flow diagram. Exercise Counseling Clinic (ECC).
Graph 1. The number of homicide cases per year discussing neuro-evidence. Unless provided in the caption above, the following copyright applies to the.
Fig. 1 Flow chart of included patients for analyses
Figure 1. Analysis of human TRIM5α protein with Blast-Search and PhyML+SMS ‘One click’ workflow. (A) NGPhylogeny.fr ... Figure 1. Analysis of human TRIM5α.
Figure 2. Natural history of chlamydia transmission, with arrows showing the transitions between health states. Figure 2. Natural history of chlamydia.
Fig. 1 Flow chart for selection of study subjects
Figure 1. Mean concentration–time profiles of ascending doses of ivermectin in (a) PSAC and (b) SAC. Weight-dependent ... Figure 1. Mean concentration–time.
Figure 1 Nelson-Aalen estimates of the cumulative incidence rates for patients on versus off IST. ON = optic neuritis; ... Figure 1 Nelson-Aalen estimates.
FIGURE 1 Malta: a plate-style food guide
Figure 1. A, Crude incidence rates per 100 person-years of follow-up and 95% confidence intervals for each solid organ ... Figure 1. A, Crude incidence.
FIGURE 1 Study consort diagram
Fig. 2 Case 2. Levels of serum creatinine and anti-GBM antibodies before and during treatment with cyclophosphamide, ... Fig. 2 Case 2. Levels of serum.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Figure 1. Illustration of DGR systems and their prediction using myDGR
FIGURE 1 Food groups consumed (mean, g/d) among US infants and young children by age group and tertile of mean ... FIGURE 1 Food groups consumed (mean,
Figure 1. The workflow of Cistrome-GO
Figure 1: Predicted probability of nest presence (0 = no nest and 1 = nest present) in response to canopy cover for ... Figure 1: Predicted probability.
Figure 1. Using Voronoi tessellation to define contacts
Figure 1. PaintOmics 3 workflow diagram
Figure 1. Schematic diagram of solar energy and coal-fired power generation system. Unless provided in the caption above, the following copyright applies.
Figure 1. Uncertainty reduction, value creation, and appropriation in two case studies. Unless provided in the caption above, the following copyright applies.
Figure 1. The configuration menu allows the user to choose among the main visualization/processing options of the ... Figure 1. The configuration menu.
Figure 1. (A) Architecture of Doc2Hpo. (B) Interactive user interface
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1. MERMAID web server interface (Start page, Parameter page): MERMAID provides two ways to submit a protein ... Figure 1. MERMAID web server interface.
Figure 1. Yvis platform overview
Figure 1. The framework of NetGO with seven steps
Figure 1. Overview of features that can be assessed in a single RegulationSpotter VCF analysis run. Depending upon a ... Figure 1. Overview of features.
Figure 1 Patient disposition
Figure 4. Healthcare utilization for paediatric diarrhoea by caregivers. Pyramid plot showing the number and ... Figure 4. Healthcare utilization for paediatric.
Figure 1 Distribution of WCD use days in WEARIT-II
Figure 1 Correlation between en face Oil-Red O staining and aortic root lesion size vs. plasma cholesterol and ... Figure 1 Correlation between en face.
Fig. 1 A network representation of top 100 co-occurring terms
Figure 1. Excess cost of methicillin-resistant Staphylococcus aureus (MRSA) compared with methicillin-susceptible S. ... Figure 1. Excess cost of methicillin-resistant.
Figure 1 Genetic results. No case had more than one diagnostic result
Figure 1 Grant agencies and charitable foundations supporting Plan S.
Figure 1. Prevalence of parasitic infection and anemia among the children. Unless provided in the caption above, the following copyright applies to the.
Figure 1. GWAS Catalog associations for coronary artery disease plotted across all chromosomes. Associations added ... Figure 1. GWAS Catalog associations.
Source:Zimnisky (2014). Source:Zimnisky (2014).
Figure 1 Mechanisms of mitral regurgitation.
Figure 2. Model adequacy results for the two empirical data sets, West African Ebola, and 2009 H1N1 influenza. The ... Figure 2. Model adequacy results.
Fig. 2. Genetic differentiation among populations and individuals
Fig. 1. Examples of plots of NanoPlot and NanoComp
Figure 1. (A) Overview of ENPD including data source, data processing and features. Transcriptomes from TSA, genomes ... Figure 1. (A) Overview of ENPD.
Figure 1 ABCDE of primary prevention.2
Fig. 1. A graphical representation of the GGDNA workflow used to identify each single expressed TE transcript from ... Fig. 1. A graphical representation.
Figure 1. Enteropathogen prevalence in stool samples collected from 996 children in the Sanitation Hygiene Infant ... Figure 1. Enteropathogen prevalence.
Presentation transcript:

Fig. 1. iS-CellR pipeline overview Fig. 1. iS-CellR pipeline overview. iS-CellR is organized into a seven-step process for complete scRNA-seq analysis. ... Fig. 1. iS-CellR pipeline overview. iS-CellR is organized into a seven-step process for complete scRNA-seq analysis. The user can interactively select steps to perform analysis using single-cell data. After uploading, the raw data are filtered and normalized. The normalized data are then subjected to dimensionality reduction for principle component analysis (PCA). Further dimensionality reduction can be performed using t-distributed stochastic neighbour embedding (tSNE). After a clustering step, differentially expressed marker genes can be visualized on cell clusters. The user can also visualize co-expression of two genes simultaneously. Inter-/intra-sample heterogeneity requires the user to upload a file with a list of genes in a two-column format (GeneSet1, GeneSet2). Finally, the user can generate a HTML report containing all results produced or download plots individually Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2018. Published by Oxford University Press.This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited. Bioinformatics, Volume 34, Issue 24, 04 July 2018, Pages 4305–4306, https://doi.org/10.1093/bioinformatics/bty517 The content of this slide may be subject to copyright: please see the slide notes for details.